Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reissue Patent
2007-04-24
2007-04-24
Jiang, S. Anna (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S007200, C536S007400
Reissue Patent
active
10752483
ABSTRACT:
Antimicrobial compounds having the formulaas well as pharmaceutically acceptable salts, esters or prodrugs thereof; pharmaceutical compositions comprising such compounds; methods of treating bacterial infections by the administration of such compounds; and processes for the preparation of the compounds.
REFERENCES:
patent: 5350839 (1994-09-01), Asaka et al.
patent: 5444051 (1995-08-01), Agouridas et al.
patent: 5527780 (1996-06-01), Agouridas et al.
patent: 5561118 (1996-10-01), Agouridas et al.
patent: 5770579 (1998-06-01), Agouridas et al.
patent: 6274715 (2001-08-01), Or et al.
patent: 0 272 110 (1988-06-01), None
patent: 0487411 (1992-05-01), None
patent: 0596802 (1994-05-01), None
patent: 0565364 (1995-06-01), None
patent: 0676409 (1995-10-01), None
patent: 0680967 (1995-11-01), None
patent: 0 638 585 (1996-11-01), None
patent: 2697524 (1994-05-01), None
patent: 2738571 (1997-03-01), None
patent: WO92/09614 (1992-06-01), None
patent: WO93/13116 (1993-07-01), None
patent: WO93/13663 (1993-07-01), None
patent: WO93/21199 (1993-10-01), None
patent: WO93/21200 (1993-10-01), None
patent: WO97/10251 (1997-03-01), None
patent: WO 97/17356 (1997-05-01), None
Pestka et al. (I), “Effect of Erythromycin Analogues on Binding of [14C]Erythromycin toEscherichia coliRibosomes,”Antimicrobial Agents and Chemotherapy,6(4), 479-488 (Oct., 1974).
Pestka et al. (II), “Correlation of Effects of Erythromycin Analogues on Intact Bacteria and on [14C]Erythromycin Binding toEscherichia coliRibosomes,”Antimicrobial Agents and Chemotherapy,6(4), 488-491 (Oct., 1974).
Pestka et al. (III), “Inhibition of [14C]Chloramphenicol Binding toEscherichia coliRibosomes by Erythromycin Derivatives,”Antimicrobial Agents and Chemotherapy,6(1), 39-45 (Jul., 1974).
Pestka et al. (IV), “Induction of Erythromycin Resistance inStaphylococcus aureusby Erythromycin Derivatives,”Antimicrobial Agents and Chemotherapy,9(1), 128-130 (Jan., 1976).
LeMahieu et al., “Glycoside Cleavage Reactions on Erythromycin A. Preparation of Erythronolide A,”Journal of Medicinal Chemistry,17(9), 953-956 (Sep., 1974).
Chu Daniel T.
Clark Richard F.
Griesgraber George
Ma Zhenkun
Or Yat Sun
Abbott Laboratories
Crane L. E.
Jiang S. Anna
Wood Phillips Katz Clark & Mortimer
LandOfFree
6-O-substituted ketolides having antibacterial activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 6-O-substituted ketolides having antibacterial activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6-O-substituted ketolides having antibacterial activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3772309